The aminopropyl-functionalized ethane-bridged bifunctional periodic mesoporous organosilicas (APEPMOs) were synthesized by the co-condensation of 1,2-bis (triethoxysilyl) ethane and 3-aminopropyltriethoxysilane in the presence of cationic surfactants octadecyltrimethylammonium chloride in basic medium. The pores of the APEPMOs were expanded with N,N-dimethyldecylamine and the pore-expanded materials were utilized as supports for β-glucosidase immobilization. A high enzyme loading of 120 mg per g support was achieved in 18 h, and 95.5 % of enzymatic activity was retained. β-Glucosidases were strongly immobilized on APEPMOs with only 5 % desorption in the washing step with buffer solution. The immobilized enzyme had 75 % activity after 20 batch reactions and had improved thermal stability, relative to the free enzyme. These results demonstrate that APEPMOs would be promising supports for β-glucosidases immobilization.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10529-013-1208-4 | DOI Listing |
Dalton Trans
January 2025
DICATECh, Politecnico di Bari, Bari, I-70125, Italy.
This systematic study delves into the synthesis and characterization of robust bi-functional aminopropyl-tagged periodic mesoporous organosilica with a high loading of small imidazolium bridges in its framework (PrNH@R-PMO-IL, ∼2 mmol g of IL). The materials proved to be a reliable and enduring support for the immobilization of Ru species, demonstrating strong performance and excellent selectivity in the -bromination of various derivatives of 2-phenylpyridine compounds and other heterocycles, showcasing its effectiveness and robust nature. The synthesized materials were thoroughly characterized to determine their structural properties, such as pore size distribution, loading of organic groups, and surface area, using various analytical techniques.
View Article and Find Full Text PDFAdv Ther
December 2024
Zenas BioPharma, 1000 Winter St, Suite 1200, Waltham, MA, 02451, USA.
Introduction: Obexelimab is an investigational, bifunctional, non-depleting, humanized monoclonal antibody that binds CD19 and FcγRIIb to inhibit B cells, plasmablasts, and CD19-expressing plasma cells. In clinical trials, intravenous (IV) administration of obexelimab has been well-tolerated, and demonstrated clinical activity in patients with rheumatoid arthritis, systemic lupus erythematosus, and immunoglobulin G4-related disease. This study was performed to evaluate the pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of obexelimab following subcutaneous (SC) administration, and compare PK/PD profiles between healthy Japanese and non-Japanese volunteers.
View Article and Find Full Text PDFJ Colloid Interface Sci
November 2024
School of Physics and Technology, University of Jinan, Jinan 250022, PR China. Electronic address:
Sluggish multi-electron transfer process of the oxygen evolution reaction (OER) hinders the further advancement of electrolysis for hydrogen production. Here, a one-dimensional multilevel stalactite-like NiS-Fe(MoS) with excellent oxygen evolution performance was successfully synthesized using a universal two-step hydrothermal method. The nanorod arrays increase the active area and promote electron transfer.
View Article and Find Full Text PDFbioRxiv
November 2024
Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853, USA.
Antibiotic tolerance, the widespread ability of diverse pathogenic bacteria to sustain viability in the presence of typically bactericidal antibiotics for extended time periods, is an understudied steppingstone towards antibiotic resistance. The Gram-negative pathogen , the causative agent of cholera, is highly tolerant to β-lactam antibiotics. We previously found that the disruption of glycolysis, via deletion of (, glucose-6-phosphate isomerase), resulted in significant cell wall damage and increased sensitivity towards β-lactam antibiotics.
View Article and Find Full Text PDFEnviron Sci Technol
November 2024
School of Environmental and Municipal Engineering, Qingdao University of Technology, Qingdao 266033, P. R. China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!